Exas stock price target

Real time Exact Sciences (EXAS) stock price quote, stock graph, news & analysis. Real time Exact Sciences (EXAS) stock price quote, stock graph, news …

CRMD updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. What to Know about the Exact Sciences–Genomic Health Deal ... Jul 29, 2019 · The ten analysts tracking Exact Sciences have an average target price of $119.89 on its stock. This target indicates a 12-month potential upside of … EXAS Stock Price & Charts | Exact Sciences In depth view into EXAS (Exact Sciences) stock including the latest price, news, dividend history, earnings information and financials.

Company insiders own 2.20% of the company’s stock. EXAS has been the topic of a number of recent analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $110.00 price target on shares of EXACT Sciences in a research report on Friday, February 14th.

About the Exact Sciences Corporation stock forecast As of 2020 April 04, Saturday current price of EXAS stock is 56.575$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Exact Sciences stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. EXAS Stock Forecast - Buy or Sell? EXACT Sciences Corporation Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.03 million more shares were traded than the day before. In total, 1.95 million shares bought and sold for approximately $112.26 million. EXAS Stock Price Summary. 30 day high of the EXAS stock price was $77.75 and low was $35.25. EXAS Stock Price and Chart — NASDAQ:EXAS — TradingView

Based on 7 analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $116.71 with a high forecast of $130.00 

EXAS | Complete Exact Sciences Corp. stock news by MarketWatch. Exact Sciences stock price target cut to $120 from $135 at Canaccord Genuity. Oct. 30  Analyst price targets provided by TipRanks. Quick Links. Advanced Charting · After Hours Quote · Analyst Research  Exact Sciences Corp. analyst ratings, historical stock prices, earnings estimates & actuals. EXAS updated stock price target summary. Exact Sciences Stock Price Forecast, EXAS stock price prediction. The best long- term & short-term Exact Sciences share price prognosis for 2020, 2021, 2022,  PARTNER NEWS: Thu, Mar 26, 3:45 PM, Zacks Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know Exact Sciences (EXAS) closed at   EXAS. Real-time BATS EXCHANGE - 03/26 04:36:29 pm. 60.51USD. -1.18%. Consensus Loading Target Price consensus revisions : last 18 months.

Possible entry level $100 Upside target $103.63 Average analysts price target $123 - Buy rating EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer.

Get the latest Exact Sciences Corporation (EXAS) stock news and headlines to help you in your trading and investing decisions. 1y Target Est: N/A: Fair Value is the appropriate price for the Exact Sciences Corporation Common Stock (EXAS) Real-Time ... EXAS's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low EXAS Price Target - ETF Channel The median EXAS price target (a different metric than the average or mean) was $126.0 as of 2020-01-22, the highest EXAS price target in the range was $135.0 while the lowest EXAS price target in the range was $110.0, with a standard deviation of $7.963. Get the latest Zacks research report on EXAS — FREE Exact Sciences (EXAS) stock price prediction is 119.528 ... About the Exact Sciences Corporation stock forecast As of 2020 April 04, Saturday current price of EXAS stock is 56.575$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Exact Sciences stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.

EXAS Stock Forecast - Buy or Sell? EXACT Sciences Corporation

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. Exact Sciences Corporation [EXAS] stock Resumed by BTIG ... 11 days ago · The new note on the price target was released on January 07, 2020, representing the official price target for Exact Sciences Corporation stock. Previously, the target price had yet another raise to $120, while Dougherty & Company analysts kept a Buy rating on EXAS stock. EXACT Sciences Is Defying Gravity - Exact Sciences ... Sep 04, 2018 · EXAS enters into a co-marketing agreement with Pfizer. EXAS's share price jumps 21% on the news. Analysts publish details of the deal but offer conflicting recommendations. EXACT Sciences (NASDAQ:EXAS) Downgraded to “Sell” at ...

EXACT SCIENCES CORPORATION : Target Price Consensus and ... Mean consensus: BUY: Number of Analysts: 17: Average target price: 106,13 $ Last Close Price: 57,60 $ Spread / Highest target How Does EXAS Stock Score on Wall Street? - InvestorsObserver Mar 06, 2020 · Wall Street is positive on EXACT Sciences Corporation (EXAS). On average, analysts give the stock a Strong Buy rating. The average price target is $123.642, which means analysts expect the stock to rise by 87.22% over the next twelve months. That averag Exact Sciences (EXAS) Stock Has 40% Upside From Here, Says ... Jan 14, 2020 · Exact Sciences (EXAS) Stock Has 40% Upside From Here, Says Analyst Maya Sasson-January 14, 2020, Murphy maintained both a Buy rating as well as a $127 price target. This conveys her confidence